Medicine

Y. Yamada, L. Rogers, D. Demanes, G. Morton, B. Prestidge, J. Pouliot, G. Cohen, M. Zaider, M. Ghilezan, I. Hsu

2012Brachytherapy

DOI: 10.1016/j.brachy.2011.09.008

tlooto Summary

The clinical outcomes for HDR are excellent, with high rates of biochemical control, even for high-risk disease, with low morbidity.

Abstract

Abstract is not available.

Citation format

YAMADA, Y., et al. American brachytherapy society consensus guidelines for high-dose-rate prostate brachytherapy. Brachytherapy, 2012, 11 1: 20–32.